HCA HEALTHCARE INC (HCA) Stock Earnings Estimates
NYSE:HCA • US40412C1018
532.3 USD
+3.64 (+0.69%)
At close: Feb 20, 2026
532.3 USD
0 (0%)
After Hours: 2/20/2026, 8:04:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 64.968B 7.86% | 70.603B 8.67% | 75.6B 7.08% | 79.453B 5.10% | 83.345B 4.90% | 87.99B 5.57% | 93.772B 6.57% | 99.903B 6.54% | 102.844B 2.94% | 107.505B 4.53% | 112.383B 4.54% | |
| EBITDA YoY % growth | 12.704B 5.67% | 13.859B 9.09% | 15.488B 11.75% | 15.986B 3.22% | 16.811B 5.16% | 17.628B 4.86% | 18.959B 7.55% | 20.097B 6.00% | 21.027B 4.63% | 21.981B 4.54% | 22.972B 4.51% | |
| EBIT YoY % growth | 9.627B 6.34% | 10.547B 9.56% | 11.965B 13.44% | 12.318B 2.95% | 12.94B 5.05% | 13.387B 3.45% | 14.765B 10.29% | 15.722B 6.48% | 16.296B 3.65% | 17.035B 4.53% | 17.803B 4.51% | |
| Operating Margin | 14.82% | 14.94% | 15.83% | 15.50% | 15.53% | 15.21% | 15.75% | 15.74% | 15.85% | 15.85% | 15.84% | |
| EPS YoY % growth | 18.66 10.41% | 22.12 18.54% | 28.38 28.30% | 30.32 6.83% | 33.44 10.31% | 37.90 13.33% | 43.67 15.21% | 50.83 16.40% | 60.18 18.39% | 68.64 14.07% | 78.36 14.16% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 7.27 12.70% | 7.54 10.34% | 7.31 4.96% | 8.24 1.21% | 7.94 9.21% | 8.35 10.87% | 8.12 11.21% | 8.96 8.80% |
| Revenue Q2Q % growth | 19.277B 5.22% | 19.622B 5.47% | 20.07B 4.74% | 20.701B 6.09% | 20.34B 5.51% | 20.606B 5.01% | 21.129B 5.28% | 21.883B 5.71% |
| EBITDA Q2Q % growth | 3.926B 5.68% | 4.027B -14.14% | 3.894B -30.18% | 4.227B -36.92% | 4.099B 4.41% | 4.228B 4.99% | 4.174B 7.19% | 4.402B 4.14% |
| EBIT Q2Q % growth | 3B 5.08% | 3.128B 5.43% | 3.055B 3.04% | 3.329B 4.75% | 3.209B 6.97% | 3.294B 5.31% | 3.267B 6.94% | 3.457B 3.84% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 8.14 44.58% | 7.53 | 0.61 | 8.05% |
| Q3 2025 Q2Q % growth | 6.96 38.37% | 5.77 | 1.19 | 20.55% |
| Q2 2025 Q2Q % growth | 6.83 23.51% | 6.31 | 0.52 | 8.18% |
| Q1 2025 Q2Q % growth | 6.45 8.77% | 5.84 | 0.61 | 10.52% |
| Q4 2024 Q2Q % growth | 5.63 -5.06% | 6.18 | -0.55 | -8.93% |
| Q3 2024 Q2Q % growth | 5.03 28.64% | 5.04 | -0.01 | -0.18% |
| Q2 2024 Q2Q % growth | 5.53 28.90% | 4.90 | 0.63 | 12.83% |
| Q1 2024 Q2Q % growth | 5.93 30.91% | 5.04 | 0.89 | 17.74% |
| Q4 2023 Q2Q % growth | 5.93 27.80% | 5.11 | 0.82 | 15.99% |
| Q3 2023 Q2Q % growth | 3.91 -0.51% | 4.02 | -0.11 | -2.67% |
| Q2 2023 Q2Q % growth | 4.29 1.90% | 4.27 | 0.02 | 0.57% |
| Q1 2023 Q2Q % growth | 4.53 9.95% | 3.97 | 0.56 | 14.11% |
| Q4 2022 Q2Q % growth | 4.64 4.98% | 4.83 | -0.19 | -3.95% |
| Q3 2022 Q2Q % growth | 3.93 -14.00% | 3.92 | 0.01 | 0.26% |
| Q2 2022 Q2Q % growth | 4.21 -3.66% | 3.74 | 0.47 | 12.68% |
| Q1 2022 Q2Q % growth | 4.12 -0.48% | 4.29 | -0.17 | -3.99% |
| Q4 2021 Q2Q % growth | 4.42 7.02% | 4.58 | -0.16 | -3.45% |
| Q3 2021 Q2Q % growth | 4.57 138.02% | 4.13 | 0.44 | 10.66% |
| Q2 2021 Q2Q % growth | 4.37 191.33% | 3.19 | 1.18 | 36.81% |
| Q1 2021 Q2Q % growth | 4.14 77.68% | 3.36 | 0.78 | 23.30% |
| Q4 2020 Q2Q % growth | 4.13 | 3.64 | 0.49 | 13.43% |
| Q3 2020 Q2Q % growth | 1.92 | 2.34 | -0.42 | -18.01% |
| Q2 2020 Q2Q % growth | 1.50 | -0.39 | 1.89 | 479.94% |
| Q1 2020 Q2Q % growth | 2.33 | 2.66 | -0.33 | -12.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 19.513B 6.72% | 19.878B | -365M | -1.84% |
| Q3 2025 Q2Q % growth | 19.161B 9.57% | 18.748B | 413M | 2.20% |
| Q2 2025 Q2Q % growth | 18.605B 6.36% | 18.68B | -75M | -0.40% |
| Q1 2025 Q2Q % growth | 18.321B 5.66% | 18.43B | -109M | -0.59% |
| Q4 2024 Q2Q % growth | 18.285B 5.68% | 18.413B | -128M | -0.70% |
| Q3 2024 Q2Q % growth | 17.487B 7.86% | 17.713B | -226M | -1.28% |
| Q2 2024 Q2Q % growth | 17.492B 10.28% | 17.217B | 275M | 1.60% |
| Q1 2024 Q2Q % growth | 17.339B 11.21% | 16.947B | 392M | 2.31% |
| Q4 2023 Q2Q % growth | 17.303B 11.65% | 16.682B | 621M | 3.72% |
| Q3 2023 Q2Q % growth | 16.213B 8.30% | 15.981B | 232M | 1.45% |
| Q2 2023 Q2Q % growth | 15.861B 7.02% | 15.772B | 89M | 0.56% |
| Q1 2023 Q2Q % growth | 15.591B 4.32% | 15.419B | 172M | 1.12% |
| Q4 2022 Q2Q % growth | 15.497B 2.87% | 15.767B | -270M | -1.71% |
| Q3 2022 Q2Q % growth | 14.971B -2.00% | 15.151B | -180M | -1.19% |
| Q2 2022 Q2Q % growth | 14.82B 2.67% | 14.872B | -52M | -0.35% |
| Q1 2022 Q2Q % growth | 14.945B 6.93% | 14.886B | 59M | 0.40% |
| Q4 2021 Q2Q % growth | 15.064B 5.39% | 15.526B | -462M | -2.98% |
| Q3 2021 Q2Q % growth | 15.276B 14.76% | 14.628B | 648M | 4.43% |
| Q2 2021 Q2Q % growth | 14.435B 30.42% | 13.756B | 679M | 4.94% |
| Q1 2021 Q2Q % growth | 13.977B 8.68% | 13.772B | 205M | 1.49% |
| Q4 2020 Q2Q % growth | 14.293B | 14.131B | 162M | 1.15% |
| Q3 2020 Q2Q % growth | 13.311B | 12.996B | 315M | 2.42% |
| Q2 2020 Q2Q % growth | 11.068B | 10.192B | 876M | 8.59% |
| Q1 2020 Q2Q % growth | 12.861B | 13.245B | -384M | -2.90% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.94% | 0.8% | 1.11% | 0.97% |
| Revenue | -0.47% | -0.53% | -0.55% | -0.7% |